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A B S T R A C T
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the skin. Although it is 40 times less
common than malignant melanoma, its mortality is much higher compared to melanoma. From 1986 to 2001 there was
rapidly increasing incidence in reported cases of MCC, with a tripling in the rate over this 15-year period. The vast ma-
jority of MCC presents on sun-exposed skin. The head and neck area is the most common site of tumor occurrence. We
present 70-year old female patient with painless red-colored nodule, size 2x2x2 cm on the dorsal side of mid left forearm.
The surgical excision with negative margins was performed, and pathohistological analysis confirmed Merkel cell carci-
noma. Sentinel lymph node biopsy was negative. In conclusion, as MCC is a very aggressive rare skin carcinoma with le-
thal outcome, it should be mandatory to perform biopsies of any suspected skin lesion.
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Introduction
Merkel cell carcinoma (MCC) is an aggressive neuro-
endocrine carcinoma with a propensity for local recur-
rence, regional lymph node metastasis, and fatal meta-
static disease. Toker was the first to describe this tumor
in 19721. It is the skin cancer with a mortality of approxi-
mately 33% at 3 year, higher than that of melanoma (ap-
proximately 15%)2. Data from epidemiology show a three-
-fold increase in MCC from 0.15 to 0.44 per 100 000 an-
nually from the years 1986 to 20013. Several factors
likely contribute to this including an aging population,
increased aggregate sun exposure and a higher number
of immune suppressed individuals. The diagnosis of MCC
is rarely made clinically. These lesions are often mis-
taken for basal cell carcinomas, cysts, squamous cell car-
cinoma, and cutaneous lymphoma. Furthermore, the ad-
vent of the immunohistochemical marker cytokeratin-20
(CK-20) improved recognition of this disease and demon-
strating the characteristic »neurosecretory granules wi-
thin cytoplasmic extensions« 4. Treatment of MCC is con-
troversial. The surgical excision with negative margins is
the first treatment and adjuvant local irradiation now is
well established but regional adjuvant (lymph nodes dis-
section or radiation therapy) remains discussed5.
We present a 70-year old female patient with skin
nodule, size 2x2x2 cm on the dorsal side of mid left fore-
arm. The surgical excision with negative margins was
performed, and pathohistological analysis confirmed
Merkel cell carcinoma. Sentinel lymph node biopsy was
negative.
Case Report
Six months prior to hospital admission a 70-year old
female noticed painless red – colored skin change on her
left arm. In March 2009 she was referred to a dermatolo-
gist due to rapid growth of skin nodule (tumor). At the
first visit painless red-colored skin nodule on the dorsal
side of mid left forearm, size 2x2x2cm was found (Figure
1a and b). The patient had no history of fever, sweats,
weight loss or fatigue. She has diagnosed hypertension
and non-insulin-dependent diabetes mellitus for eight
years. The patient was admitted to our Department of
Dermatovenerology for further examinations. Routine
laboratory tests revealed only sideropenic anemia and
hyperglycemia. Therefore gastrointestinal endoscopic
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examinations were performed and revealed ventricular
erosions while tumor was excluded. In addition, stool
tests for occult bleeding were negative, as well as tumor
markers. Chest radiograph and abdominal ultrasound
findings were normal.
The skin tumor was surgically removed completely
and pathohystological diagnosis was Merkel cell carci-
noma (MCC). Immunohystochemical staining showed tu-
mor cells positive for neuron-specific enolase (NSE) with
perinuclear expression of cytokeratin 20 and neurofila-
ment. Sentinel lymph node biopsy was negative; accord-
ingly disease was localized on primary skin lesion (stage
II).
Regular appointments for skin and lymph nodes ex-
aminations were performed every 3 months, without re-
currence of skin changes, so no additional therapy was
initiated.
Discussion
Merkel cell carcinoma (MCC) is a rare, highly aggres-
sive skin cancer with rapidly increasing incidence during
last few decades3. Similarly, incidence of melanoma is in-
creasing worldwide as well in Croatia, reported by Buljan
et al6. Mortality of MCC is approximately 33% at 3
years2, higher compared to melanoma (15%). The tumor
is most commonly found in sun exposed areas (head and
neck), suggesting ultraviolet radiation as a possible etio-
logic factor Other risk factors as imunosuppression and
viral infection could play role in pathogenesis of MCC as
there are reports of MCC cases in kidney transplant
patients7,8. The most significant features can be summa-
rized in an acronym AEIOU – Asymptomatic, Expanding
rapidly, Immune suppression, Older than age 50, and
UV-exposed site in person with fair skin9. The group of
American Joint Committee on Cancer recently proposed
a modified 4-tiered system that separates patients with
localized disease into stage I (primary tumor dimension
less then 2cm) and stage II (primary tumor dimension
larger or equal 2cm). Patient with regional or distant
metastatic disease are classified as stage III and IV 2.
Our 70-year old female patient presented with grow-
ing skin nodule size 2x2x2cm on the left forearm. The
skin tumor was surgically removed completely and pa-
thohystological diagnosis was Merkel cell carcinoma
(MCC). Immunohystochemical staining showed tumor
cells positive for neuron-specific enolase (NSE) with pe-
rinuclear expression of cytokeratin 20 and neurofila-
ment. Sentinel lymph node biopsy (SLNB) is generally
accepted method in determining status of lymph nodes in
patients with malignant melanoma10, hence SLNB was
performed in our patient to obtain staging and prognosis
of MCC. SLNB was negative; therefore disease was local-
ized on primary skin lesion (stage II). There is no explicit
algorithm for local radiological therapy in MCC stage I
and II 11. We confer with oncologists which recommended
no additional therapy for this patient after surgical exci-
sion of skin tumor. During the follow up in next 8 months
there was no recurrence of tumor; and so we are plan-
ning to perform regular visits every 3–6 months.
Conclusion
MCC is a very aggressive rare skin carcinoma with le-
thal outcome, therefore it should be mandatory to per-
form biopsies of any suspected skin lesion.
R E F E R E N C E S
1. TOKER C, Arch Dermatol, 105 (1972) 107. — 2. ALLEN PJ, BOW-
NE WB, JAQUES DP, BRENNAN MF, BUSAN K, COIT DG, J Clin Oncol,
23 (2005) 2300. — 3. HODGSON NC, J Surg Oncol, 89 (2005) 1. — 4.
GOEPFERT H, REMMLER D, SILVA E, WHEELER B, J Clin Oncol, 110
(1984) 707. — 5. GUIHARD S, NOËL G, Cancer/Radiotherapie, 13 (2009)
47. — 6. BULJAN M, RAJA^I] N, VURNEK @IVKOVI] M, BLAJI] I,
KUSI] Z, [ITUM M, Coll Antropol, 32 (2008) 47. — 7. BA[I]-JUKI] N,
BUBI]-FILIPI LJ, KES P, [EPAROVI] V, [MALCELJ J, [TITI] V, HU-
DOLIN T, PASINI J, Acta Clin Croat, 46 (2007) 255. — 8. WILLIAMS RH,
MORGAN MB, MATHIESON IM, RABB H, Transplantation, 65 (1998)
1396. — 9. HEATH M, JAIMES N, LEMOS B, MOSTAGHIMI A, WANG
CL, PENAS P, NGHIEM P, J Am Acad Dermatol, 58 (2008) 375. — 10.
N. [usti} et al.: Merkel Cell Carcinoma, Coll. Antropol. 34 (2010) Suppl. 2: 291–293
292
Fig. 1. a) and b) 70-year old female patient with skin nodule on
the dorsal side of mid left forearm (Merkell cell carcinoma)
a)
b)
HOMOLAK D, VU^ETI] B, PULJIZ Z, BLAJI] I, VURNEK @IVKOVI]
M, [ITUM M, Coll Antropol, 32 (2008) 57. — 11. ENG TY, BOERSMA
MG, FULLER CD, CAVANAUGH SX, VALENZUELA F, HERMAN TS,
Am J Clin Oncol, 27 (2004) 510.
N. [usti}
Department of Dermatology Clinical Hospital Osijek, Huttlerova 4, 31000 Osijek, Croatia
e-mail: sustic.nela@kbo.hr
KARCINOM MERKELOVIH STANICA: PRIKAZ SLU^AJA
S A @ E T A K
Karcinom Merkelovih stanica (MCC) je rijedak agresivni tumor ko`e koji nastaje iz neuroendokrinih stanica. Iako je
40 puta rje|i od malignog melanoma, MCC ima znatno vi{i mortalitet. U periodu od 1986. do 2001. godine zabilje`en je
brzi porast incidencije MCC, tako da se u posljednjih 15 godina incidencija utrostru~ila. Velika ve}ina MCC se javlja na
fotoeksponiranim dijelovima ko`e, naro~ito na glavi i vratu. Prikazali smo 70-godi{nju bolesnicu s bezbolnim crven-
kastim nodusom, veli~ine 2x2x2 cm na dorzalnoj strani srednjeg dijela lijeve podlaktice. U~injena je kirur{ka ekscizija
tumora u cijelosti (negativni rubovi), te je patohistolo{kom dijagnozom potvr|en MCC. Odstranjen je i sentinal limfni
~vor koji je ispao negativan. U zaklju~ku, budu}i da je MCC rijedak, vrlo agresivan ko`ni tumor sa smrtnim ishodom,
potrebno je u~initi biopsiju svake sumnjive ko`ne promjene.
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